Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Immunic, Inc. (IMUX) had Normalized Income after Taxes of $-34.10M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-34.10M |
|
-- |
|
-- |
|
$35.33M |
|
$-35.33M |
|
$1.23M |
|
$-34.10M |
|
$-34.10M |
|
$-34.10M |
|
$-34.10M |
|
$-34.10M |
|
|
Normalized Income after Taxes |
$-34.10M |
$-35.33M |
|
$-35.29M |
|
42.51M |
|
42.51M |
|
$-0.80 |
|
$-0.80 |
|
| Balance Sheet Financials | |
$157.83M |
|
$0.77M |
|
$1.34M |
|
$159.17M |
|
$31.26M |
|
-- |
|
$0.33M |
|
$31.59M |
|
$127.58M |
|
$127.58M |
|
$127.58M |
|
13.64M |
|
| Cash Flow Statement Financials | |
$-48.30M |
|
$-0.25M |
|
$188.76M |
|
$15.48M |
|
$155.10M |
|
$139.62M |
|
$11.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.05 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-48.55M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-26.73% |
|
-26.73% |
|
-21.42% |
|
-26.73% |
|
$9.35 |
|
$-1.14 |
|
$-1.14 |
|